Hetrazan is a trademarked brand name of the generic drug called Diethylcarbamazine (DEC), which is primarily used to treat various parasitic infections, particularly infections caused by filarial worms. It belongs to a group of medications known as anthelmintics or antiparasitic drugs.
Diethylcarbamazine, under the brand name Hetrazan, is primarily used in the treatment of lymphatic filariasis, a disease caused by filarial worms that are transmitted through mosquito bites. This condition affects the lymphatic system, leading to swelling and deformities in the limbs, known as elephantiasis, or in the scrotum, known as hydrocele. By targeting and killing the worms, Hetrazan helps reduce the symptoms and prevent further transmission of the disease.
Aside from its use in treating lymphatic filariasis, Hetrazan is also sometimes prescribed for the treatment of other parasitic infections, such as loiasis, a condition caused by the Loa loa worm, which is commonly found in Central and West Africa.
Hetrazan is generally available in tablet form and should be taken orally under the supervision of a healthcare professional. The dosage and duration of treatment may vary depending on the specific infection being treated and the individual's medical history.
As with any medication, Hetrazan may have side effects, including nausea, vomiting, dizziness, and headache. It is important to consult a healthcare professional before starting this medication and to follow the prescribed dosage and course of treatment for optimal effectiveness and safety.
